Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr α-synuclein mutation

被引:193
作者
Spira, PJ
Sharpe, DM
Halliday, G
Cavanagh, J
Nicholson, GA
机构
[1] Univ Sydney, Concord Hosp, Mol Med Lab, Dept Mol Med, Concord, NSW 2139, Australia
[2] Prince Wales Hosp, Inst Neurosci, Randwick, NSW 2031, Australia
[3] Prince Wales Med Res Inst, Randwick, NSW 2031, Australia
[4] Concord Hosp, Dept Neurol, Concord, NSW, Australia
关键词
D O I
10.1002/ana.67.abs
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We describe an Australian family of Greek origin with a parkinsonian syndrome and an Ala53Thr alpha -synuclein gene mutation. Five of 9 siblings were affected, the average age of onset was 45 years, and the initial symptoms were variable, including resting tremor, bradykinesia, and gait disturbance, as previously described in families with the same point mutation. Affected family members responded well to levodopa, developed progressive cognitive impairment, and had a disease duration of 5 to 16 years. Pathologic features typical of idiopathic Parkinson's disease were found at autopsy. However, there were several additional features not previously reported in families with this gene mutation. These features included severe central hypoventilation, orthostatic hypotension, prominent myoclonus, and urinary incontinence. An abundance of alpha -synuclein-immunoreactive Lewy neurites were found in the brainstem pigmented nuclei, hippocampus, and temporal neocortex. The Lewy neurites were associated with temporal lobe vacuolation. Subcortical basal ganglia cell loss and gliosis were seen. These additional clinical and pathological features suggest that the Ala53Thr alpha -synuclein mutation can produce a more widespread disorder than found in typical idiopathic Parkinson's disease.
引用
收藏
页码:313 / 319
页数:7
相关论文
共 44 条
  • [1] Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding α-synuclein
    Athanassiadou, A
    Voutsinas, G
    Psiouri, L
    Leroy, E
    Polymeropoulos, MH
    Ilias, A
    Maniatis, GM
    Papapetropoulos, T
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (02) : 555 - 558
  • [2] The genetics of Parkinson's disease and parkinsonian syndromes
    Bajaj, NPS
    Shaw, C
    Warner, T
    RayChaudhuri, K
    [J]. JOURNAL OF NEUROLOGY, 1998, 245 (10) : 625 - 633
  • [3] FAMILIAL PARKINSONISM WITH DEPRESSION - A CLINICOPATHOLOGICAL STUDY
    BHATIA, KP
    DANIEL, SE
    MARSDEN, CD
    [J]. ANNALS OF NEUROLOGY, 1993, 34 (06) : 842 - 847
  • [4] Buchman VL, 1998, MOL BIOL+, V32, P485
  • [5] Caviness JN, 1996, MAYO CLIN PROC, V71, P679
  • [6] Cortical myoclonus in levodopa-responsive parkinsonism
    Caviness, JN
    Adler, CH
    Newman, S
    Caselli, RJ
    Muenter, MD
    [J]. MOVEMENT DISORDERS, 1998, 13 (03) : 540 - 544
  • [7] Caviness JN, 2000, MOVEMENT DISORD, V15, P140, DOI 10.1002/1531-8257(200001)15:1<140::AID-MDS1022>3.0.CO
  • [8] 2-5
  • [9] Familial Parkinsonism, dementia, and Lewy body disease: Study of Family G
    Denson, MA
    Wszolek, ZK
    Pfeiffer, RF
    Wszolek, EK
    Paschall, TM
    McComb, RD
    [J]. ANNALS OF NEUROLOGY, 1997, 42 (04) : 638 - 643
  • [10] Dickson DW, 1999, BRAIN PATHOL, V9, P657